Skip to content
StockMarketAgent
Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

NNOX stock hub

Nano-X Imaging Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NNOXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
120.4M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
NNOX
In the news

Latest news · NNOX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-45.6
P25 -105.6P50 -46.5P75 -3.1
ROIC-22
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NNOX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
200
Groups with data
11
Currency
USD
Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001795251
Company name
Nano-X Imaging Ltd.
Country
Israel
Country code
US
Cusip
M70700105
Employees
165
Employees Change
1%
Employees Change Percent
0.61
Enterprise value
$68.6M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Medical Devices
IPO Date
2020-08-21
Isin
IL0011681371
Last refreshed
2026-05-10
Market cap
$120.4M
Market cap category
Micro-Cap
Price
$1.73
Price currency
USD
Rev Per Employee
78,915.15x
Sector
Healthcare
Sic
3844
Symbol
NNOX
Website
https://www.nanox.vision

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-62.31%
EV Sales Forward
2.13x
EV/Sales
5.27x
FCF yield
-37.38%
P/B ratio
0.86x
P/S ratio
9.25x
PS Forward
3.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

12
MetricValue
Gross margin
-98.21%
Gross Profit
$-12.8M
Net Income
$-75M
Net Income Growth Years
0%
Pretax Margin
-589.89%
Profit Per Employee
$-454,655
ROA
-20.37
Roa5y
-16.75
ROCE
-41.74
ROE
-45.62
Roe5y
-34.22
ROIC
-22.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr1y
-65%
Cagr3y
-51.56%
Cagr5y
-43.14%
EPS Growth Years
0
Revenue Growth
15.4x
Revenue Growth Q
23.97x
Revenue Growth Quarters
13x
Revenue Growth Years
4x
Revenue Growth3 Y
14.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
$0.07
Assets
$162.2M
Cash
$59.6M
Current Assets
$66.8M
Current Liabilities
$16.9M
Debt
$7.9M
Debt Equity
$0.06
Equity
$139.7M
Liabilities
$22.4M
Long Term Assets
$95.4M
Long Term Liabilities
$5.5M
Net Cash
$51.8M
Net Cash By Market Cap
$42.99
Net Cash Growth
-21.29%
Net Debt Equity
$-0.37
Tangible Book Value
$79.5M
Tangible Book Value Per Share
$1.14
WACC
10.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
3.96
Inventory Turnover
11.31
Net Working Capital
$-5.6M
Quick ratio
3.65
Working Capital
$49.9M
Working Capital Turnover
$0.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-10.43%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
1Y total return
-64.98%
200-day SMA
3.25
3Y total return
-88.64%
50-day SMA
2.28
50-day SMA vs 200-day SMA
50under200
5Y total return
-94.05%
All Time High
94.81
All Time High Change
-98.18%
All Time High Date
2021-01-27
All Time Low
1.66
All Time Low Change
4.22%
All Time Low Date
2026-04-30
ATR
0.15
Beta
1.18
Beta1y
1.45
Beta2y
1.46
Ch YTD
-38.21
High
1.78
High52
5.86
High52 Date
2025-05-13
High52ch
-70.48%
Low
1.73
Low52
1.66
Low52 Date
2026-04-30
Low52ch
4.22%
Ma50ch
-24.16%
Premarket Change Percent
-1.7
Premarket Price
$1.73
Premarket Volume
52,820
Price vs 200-day SMA
-46.72%
RSI
36.67
RSI Monthly
35.9
RSI Weekly
35.24
Sharpe ratio
-1.17x
Sortino ratio
-1.59
Total Return
-10.43%
Tr YTD
-38.21
Tr1m
-24.78%
Tr3m
-29.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

9
MetricValue
Analyst Count
1
Analyst Ratings
Strong Buy
Earnings EPS Estimate
$-0.09
Earnings Revenue Estimate
5,513,250x
Earnings Revenue Estimate Growth
95.85x
Operating Income
$-60.6M
Operating margin
-465.7
Price target
$5
Price Target Change
$189

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
69,381,977%
Float Percent
99.7%
Shares Insiders
0.3%
Shares Institutions
23.48%
Shares Out
69,590,228
Shares Qo Q
4.25%
Shares Yo Y
10.43%
Short Float
14.65%
Short Ratio
12.33
Short Shares
14.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
$-49.2M
Average Volume
2,259,649.2x
Bv Per Share
2.01
CAPEX
$-4.2M
Ch1m
-24.78
Ch1y
-64.98
Ch3m
-29.1
Ch3y
-88.64
Ch5y
-94.05
Ch6m
-43.28
Change
-1.7%
Change From Open
-0.57
Close
1.76
Days Gap
-1.14
Depreciation Amortization
11,697,000
Dollar Volume
2,124,960.7
Earnings Date
2026-05-20
Earnings Time
bmo
EBIT
$-60.6M
EBITDA
$-48.9M
EPS
$-1.16
F Score
2
FCF
$-45M
FCF EV Yield
-65.57x
FCF Per Share
$-0.65
Financing CF
21,368,000
Fiscal Year End
December
Founded
2,011
Goodwill
316,000
Income Tax
$-1.8M
Investing CF
29,373,000
Ipr
-90.39
Iprfo
-91.49
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-04-20
Last Report Date
2025-12-31
Last Split Type
Never
Last10k Filing Date
2026-04-30
Ma150
2.93
Ma150ch
-41.02%
Ma20
2.03
Ma20ch
-14.65%
Net CF
9,847,000
Next Earnings Date
2026-05-21
Open
1.74
Optionable
Yes
Position In Range
0
Post Close
1.73
Postmarket Change Percent
-0.57
Postmarket Price
$1.72
Ppne
20,896,000
Pre Close
1.76
Price Date
2026-05-08
Ptbv Ratio
1.51
Relative Volume
0.54x
Revenue
13,021,000x
SBC By Revenue
32.18x
Share Based Comp
4,190,000
Tax By Revenue
-13.76x
Tr6m
-43.28%
Volume
1,228,301
Z Score
3.67
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does NNOX pay a dividend?

Capital-return profile for this ticker.

Performance

NNOX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-65.0%
S&P 500 1Y: n/a
3Y total return
-88.6%
S&P 500 3Y: n/a
5Y total return
-94.1%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns NNOX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+23.5%
Float: +99.7% of shares outstanding
Insider ownership
+0.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+14.7%
12.3 days to cover
Y/Y dilution
+10.4%
Negative means the company is buying back shares.
Technical

NNOX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
36.7
Neutral momentum band
Price vs 200-day MA
-46.7%
50/200-day relationship not available
Beta (5Y)
1.18
Moves roughly with the market
Sharpe ratio
-1.17
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NNOX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NNOX stock rating?

Nano-X Imaging Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NNOX analysis?

The full report lives at /stocks/NNOX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NNOX?

The latest report frames NNOX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NNOX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.